Status:
TERMINATED
High Flow Nasal Cannula (HFNC) Initiation Flow Rate Study
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Bronchiolitis
Eligibility:
All Genders
7-12 years
Phase:
NA
Brief Summary
The investigators propose an open label, non-blinded, single center randomized controlled feasibility study to find the optimal initial HFNC flow rate in children less than 12 months old with clinical...
Eligibility Criteria
Inclusion
- Patients less than 12 months of age
- Clinical signs of moderate to severe bronchiolitis defined by American Academy of Pediatrics
- Requires ICU level of care by clinicians' discretion
- Requiring HFNC support
Exclusion
- Infants who required immediate need for respiratory support such as non-invasive positive pressure ventilation (NIPPV) or invasive ventilation
- Congenital heart disease,
- Immunocompromised state
- Upper airway obstruction
- Chronic lung disease
- Bronchopulmonary dysplasia,
- Home oxygen therapy requirement
- Acute trauma patients
- Baseline craniofacial malformations
- Admitted to the neonatal or cardiac ICUs
- Patients who are admitted to the floor
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2025
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04517344
Start Date
December 1 2020
End Date
April 1 2025
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Health - Children's Medical Center
Dallas, Texas, United States, 75235